SG11201700703XA - Salt of monocyclic pyridine derivative and crystal thereof - Google Patents
Salt of monocyclic pyridine derivative and crystal thereofInfo
- Publication number
- SG11201700703XA SG11201700703XA SG11201700703XA SG11201700703XA SG11201700703XA SG 11201700703X A SG11201700703X A SG 11201700703XA SG 11201700703X A SG11201700703X A SG 11201700703XA SG 11201700703X A SG11201700703X A SG 11201700703XA SG 11201700703X A SG11201700703X A SG 11201700703XA
- Authority
- SG
- Singapore
- Prior art keywords
- salt
- crystal
- pyridine derivative
- monocyclic pyridine
- monocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014166118 | 2014-08-18 | ||
| PCT/JP2015/073047 WO2016027781A1 (ja) | 2014-08-18 | 2015-08-17 | 単環ピリジン誘導体の塩およびその結晶 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201700703XA true SG11201700703XA (en) | 2017-03-30 |
Family
ID=55350725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201700703XA SG11201700703XA (en) | 2014-08-18 | 2015-08-17 | Salt of monocyclic pyridine derivative and crystal thereof |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9951047B2 (pt) |
| EP (1) | EP3184520B1 (pt) |
| JP (1) | JP5925978B1 (pt) |
| KR (1) | KR102344105B1 (pt) |
| CN (1) | CN106660997B (pt) |
| AU (1) | AU2015304465B2 (pt) |
| BR (1) | BR112017002268B1 (pt) |
| CA (1) | CA2956270C (pt) |
| ES (1) | ES2914072T3 (pt) |
| IL (1) | IL250290B (pt) |
| MX (1) | MX369646B (pt) |
| RU (1) | RU2658821C1 (pt) |
| SG (1) | SG11201700703XA (pt) |
| WO (1) | WO2016027781A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6858132B2 (ja) * | 2015-12-17 | 2021-04-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 乳がん治療剤 |
| BR112020003849A2 (pt) * | 2017-10-12 | 2020-09-08 | Eisai R&D Management Co., Ltd. | composição farmacêutica compreendendo inibidor seletivo de tirosina quinase fgfr |
| MX2020008610A (es) | 2018-03-28 | 2020-09-21 | Eisai R&D Man Co Ltd | Agente terapeutico para carcinoma hepatocelular. |
| CN115397415A (zh) | 2020-04-17 | 2022-11-25 | 卫材R&D管理有限公司 | 乳腺癌治疗剂 |
| EP4151212A4 (en) | 2020-07-31 | 2024-04-10 | Eisai R&D Man Co Ltd | THERAPEUTIC AGENT AGAINST BREAST CANCER |
| CN116390757A (zh) | 2020-10-28 | 2023-07-04 | 卫材R&D管理有限公司 | 用于治疗肿瘤的药物组合物 |
| JP7315805B1 (ja) | 2021-08-31 | 2023-07-26 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 単環ピリジン誘導体の合成中間体の製造方法 |
| TW202328099A (zh) | 2021-08-31 | 2023-07-16 | 日商衛材R&D企管股份有限公司 | 單環吡啶衍生物之製造方法 |
| CN116768856A (zh) * | 2022-03-18 | 2023-09-19 | 上海润石医药科技有限公司 | 一种取代的氨基六元氮杂环类化合物的盐及其晶型、制备方法和应用 |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10006139A1 (de) | 2000-02-11 | 2001-08-16 | Merck Patent Gmbh | Indol-3-yl-Derivate |
| EP1777218B1 (en) | 2000-10-20 | 2008-12-31 | Eisai R&D Management Co., Ltd. | Process for the preparation of 4-phenoxy quinoline derivatives |
| US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
| WO2004020434A1 (ja) | 2002-08-30 | 2004-03-11 | Eisai Co., Ltd. | 含窒素芳香環誘導体 |
| US7098332B2 (en) | 2002-12-20 | 2006-08-29 | Hoffmann-La Roche Inc. | 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones |
| RU2350617C2 (ru) | 2003-04-10 | 2009-03-27 | Ф.Хоффманн-Ля Рош Аг | Пиримидиновые соединения, обладающие свойствами селективного ингибирования активности кдр и фрфр |
| US20050256154A1 (en) | 2004-05-04 | 2005-11-17 | Kin-Chun Luk | 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides |
| GB0512324D0 (en) | 2005-06-16 | 2005-07-27 | Novartis Ag | Organic compounds |
| FR2883286B1 (fr) | 2005-03-16 | 2008-10-03 | Sanofi Aventis Sa | NOUVEAUX DERIVES D'IMIDAZO[1,5-a]PYRIDINES, INHIBITEURS DE FGFs, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT |
| EP2270000B1 (en) | 2005-05-23 | 2015-07-29 | Novartis AG | Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts |
| EP1976847B1 (en) | 2005-12-21 | 2015-06-17 | Novartis AG | Pyrimidinyl aryl urea derivatives being fgf inhibitors |
| TW200811134A (en) | 2006-07-12 | 2008-03-01 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| EP1891955A1 (en) | 2006-07-24 | 2008-02-27 | Sanofi-Aventis | Use of 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, for the preparation of a medicament intended for the treatment of degenerative joint diseases |
| US7737149B2 (en) | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
| AU2007337895C1 (en) | 2006-12-22 | 2014-07-31 | Astex Therapeutics Limited | Tricyclic amine derivatives as protein tyrosine kinase inhibitors |
| US8131527B1 (en) | 2006-12-22 | 2012-03-06 | Astex Therapeutics Ltd. | FGFR pharmacophore compounds |
| US8895745B2 (en) | 2006-12-22 | 2014-11-25 | Astex Therapeutics Limited | Bicyclic heterocyclic compounds as FGFR inhibitors |
| CA2690355A1 (en) | 2007-06-25 | 2008-12-31 | Qinetiq Limited | Preconcentrator device incorporating a polymer of intrinsic microporosity |
| WO2009019518A1 (en) | 2007-08-09 | 2009-02-12 | Astrazeneca Ab | Pyrimidine compounds having a fgfr inhibitory effect |
| GB0720038D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New compounds |
| GB0720041D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New Compounds |
| WO2009056886A1 (en) | 2007-11-01 | 2009-05-07 | Astrazeneca Ab | Pyrimidine derivatives and their use as modulators of fgfr activity |
| CL2008003675A1 (es) | 2007-12-13 | 2009-03-20 | Wyeth Corp | Compuestos derivados de 5-alquil o alquenil 3-cianopiridinas, procedimiento de preparacion, composicion farmaceutica, util para reducir la actividad incrementada de una enzima en un mamifero, en donde dicha enzima es una proteina quinasa, destinado al tratamiento de la inflamacion, asma, colitis, esclerosis multiple, soriasis, artritis reumatoide. |
| MX2010012699A (es) | 2008-05-23 | 2010-12-07 | Novartis Ag | Derivados de quinolinas y quinoxalinas como inhibidores de cinasa de proteina tirosina. |
| GB0810902D0 (en) | 2008-06-13 | 2008-07-23 | Astex Therapeutics Ltd | New compounds |
| JP2011524888A (ja) | 2008-06-19 | 2011-09-08 | アストラゼネカ アクチボラグ | ピラゾール化合物４３６ |
| AU2009335016A1 (en) | 2008-12-30 | 2011-08-18 | Arqule, Inc. | Substituted pyrazolo [3, 4-b] pyridine compounds |
| CN102325755B (zh) | 2008-12-30 | 2015-07-01 | 艾科尔公司 | 取代的5,6-二氢-6-苯基苯并[f]异喹啉-2-胺化合物 |
| US8273754B2 (en) | 2008-12-30 | 2012-09-25 | Arqule, Inc. | Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds |
| US9002427B2 (en) | 2009-03-30 | 2015-04-07 | Lifewave Biomedical, Inc. | Apparatus and method for continuous noninvasive measurement of respiratory function and events |
| GB0906470D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| GB0906472D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| EP2270043A1 (en) | 2009-07-03 | 2011-01-05 | Sanofi-Aventis | Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor |
| FR2947546B1 (fr) | 2009-07-03 | 2011-07-01 | Sanofi Aventis | Derives de pyrazoles, leur preparation et leur application en therapeutique |
| IN2012DN01249A (pt) | 2009-08-07 | 2015-05-15 | Chugai Pharmaceutical Co Ltd | |
| CN102596916B (zh) | 2009-10-30 | 2015-06-17 | 诺瓦提斯公司 | 3-(2,6-二氯-3,5-二甲氧基-苯基)-1-{6-[4-(4-乙基-哌嗪-1-基)-苯基氨基]-嘧啶-4-基}-1-甲基-脲的n-氧化物 |
| AR079257A1 (es) | 2009-12-07 | 2012-01-04 | Novartis Ag | Formas cristalinas de 3-(2,6-dicloro-3-5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea y sales de las mismas |
| GB201007286D0 (en) | 2010-04-30 | 2010-06-16 | Astex Therapeutics Ltd | New compounds |
| FR2962437B1 (fr) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique |
| GB201020179D0 (en) | 2010-11-29 | 2011-01-12 | Astex Therapeutics Ltd | New compounds |
| US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
| EP2548877A1 (en) * | 2011-07-19 | 2013-01-23 | MSD Oss B.V. | 4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors |
| CN106243113B (zh) | 2011-07-19 | 2018-12-18 | 默沙东有限责任公司 | 作为btk抑制剂的选择的咪唑并吡嗪类 |
| GB201118656D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
| GB201118652D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
| GB201118654D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
| GB201118675D0 (en) | 2011-10-28 | 2011-12-14 | Astex Therapeutics Ltd | New compounds |
| FR2984325A1 (fr) | 2011-12-14 | 2013-06-21 | Sanofi Sa | Derives de pyrazolopyridine, leur procede de preparation et leur application en therapeutique |
| US9108973B2 (en) | 2012-01-19 | 2015-08-18 | Taiho Pharmaceutical Co., Ltd. | 3,5-disubstituted alkynylbenzene compound and salt thereof |
| ES2746288T3 (es) | 2012-02-28 | 2020-03-05 | Astellas Pharma Inc | Compuesto heterocíclico aromático que contiene nitrógeno |
| GB201209609D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
| LT3176170T (lt) | 2012-06-13 | 2019-04-25 | Incyte Holdings Corporation | Pakeisti tricikliniai junginiai, kaip fgfr inhibitoriai |
| EP2871236A4 (en) | 2012-07-05 | 2016-03-09 | Nat Cancer Ct | HYBRID FGFR2 GENE |
| DK2872491T3 (da) | 2012-07-11 | 2021-08-09 | Blueprint Medicines Corp | Inhibitorer af fibroblastvækstfaktorreceptoren |
| WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
| WO2014044846A1 (en) | 2012-09-24 | 2014-03-27 | Evotec (Uk) Ltd. | 3-(aryl- or heteroaryl-amino)-7-(3,5-dimethoxyphenyl)isoquinoline derivatives as fgfr inhibitors useful for the treatment of proliferative disorders or dysplasia |
| WO2014048878A1 (en) | 2012-09-26 | 2014-04-03 | Evotec (Uk) Ltd. | Phenyl- or pyridyl- pyrrolo[2,3b]pyrazine derivatives useful in the treatment or prevention of proliferative disorders or dysplasia |
| TWI606066B (zh) | 2012-09-27 | 2017-11-21 | 中外製藥股份有限公司 | FGFR3 Fusion Gene and Its Targeted Medicine |
| AR094812A1 (es) * | 2013-02-20 | 2015-08-26 | Eisai R&D Man Co Ltd | Derivado de piridina monocíclico como inhibidor del fgfr |
| TWI628176B (zh) | 2013-04-04 | 2018-07-01 | 奧利安公司 | 蛋白質激酶抑制劑 |
-
2015
- 2015-08-17 RU RU2017103439A patent/RU2658821C1/ru active
- 2015-08-17 BR BR112017002268-0A patent/BR112017002268B1/pt active IP Right Grant
- 2015-08-17 AU AU2015304465A patent/AU2015304465B2/en active Active
- 2015-08-17 MX MX2017001624A patent/MX369646B/es active IP Right Grant
- 2015-08-17 CN CN201580042132.3A patent/CN106660997B/zh active Active
- 2015-08-17 JP JP2015560425A patent/JP5925978B1/ja active Active
- 2015-08-17 KR KR1020177002791A patent/KR102344105B1/ko active IP Right Grant
- 2015-08-17 CA CA2956270A patent/CA2956270C/en active Active
- 2015-08-17 EP EP15834302.0A patent/EP3184520B1/en active Active
- 2015-08-17 US US15/500,429 patent/US9951047B2/en active Active
- 2015-08-17 SG SG11201700703XA patent/SG11201700703XA/en unknown
- 2015-08-17 WO PCT/JP2015/073047 patent/WO2016027781A1/ja active Application Filing
- 2015-08-17 ES ES15834302T patent/ES2914072T3/es active Active
-
2017
- 2017-01-25 IL IL250290A patent/IL250290B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ES2914072T3 (es) | 2022-06-07 |
| MX2017001624A (es) | 2017-04-27 |
| US20170217935A1 (en) | 2017-08-03 |
| CN106660997B (zh) | 2019-05-21 |
| BR112017002268B1 (pt) | 2022-11-08 |
| MX369646B (es) | 2019-11-15 |
| IL250290A0 (en) | 2017-03-30 |
| RU2658821C1 (ru) | 2018-06-25 |
| EP3184520A4 (en) | 2018-04-18 |
| CA2956270C (en) | 2022-08-09 |
| BR112017002268A2 (pt) | 2017-11-21 |
| KR102344105B1 (ko) | 2021-12-29 |
| AU2015304465A1 (en) | 2017-02-23 |
| AU2015304465B2 (en) | 2019-05-09 |
| US9951047B2 (en) | 2018-04-24 |
| JP5925978B1 (ja) | 2016-05-25 |
| IL250290B (en) | 2020-06-30 |
| KR20170035927A (ko) | 2017-03-31 |
| EP3184520B1 (en) | 2022-03-23 |
| CN106660997A (zh) | 2017-05-10 |
| EP3184520A1 (en) | 2017-06-28 |
| CA2956270A1 (en) | 2016-02-25 |
| WO2016027781A1 (ja) | 2016-02-25 |
| JPWO2016027781A1 (ja) | 2017-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2542881B (en) | Crystal forms of ß-nicotinamide mononucleotide | |
| IL250290B (en) | A salt of a monocyclic pyridine derivative and its crystalline form | |
| HRP20190432T1 (hr) | Spojevi pladienolid piridina i postupci uporabe | |
| HK1245774A1 (zh) | Copanlisib及其二鹽酸鹽的合成 | |
| HRP20190527T1 (hr) | Sinteza kopanlisiba i njegove dihidrokloridne soli | |
| SG11201507897SA (en) | Salt of pyrazoloquinoline derivative, and crystal thereof | |
| ZA201701066B (en) | Pyridine derivatives and anti-mycobacterial use thereof | |
| IL253018A0 (en) | Crystalline forms of apomorphine and their uses | |
| EP3107540A4 (en) | Polymorphs of lomitapide and its salts | |
| SG11201605915WA (en) | Furo-3-carboxamide derivatives and methods of use | |
| ZA201901155B (en) | Salt and crystal of diaza-benzofluorane compound | |
| PT3395819T (pt) | Forma cristalina de derivado de aminopirano substituído | |
| AU2014901403A0 (en) | Combination of crystals and water |